Surrozen Inc
Biotechnology
Healthcare
SRZN
3.63 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
12.50
52 week high
17.02
high
12.50
52 week low
0.00
low
11.79
growth
36.19 %
previous Close
12.20
P/E ratio
-11
market cap
81.86 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
-1.14 %
84.70 %
eps surprise
7.55 %
net profit margin
0.00 %
2743.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top